Matchpoint Therapeutics Inc.

Pharmaceutical company · Cambridge, Massachusetts, United States

Matchpoint Therapeutics Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $42 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Matchpoint Therapeutics at a glance

Typepharmaceutical company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2021

SEC CIK1950915

What does Matchpoint Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $42 million sold (2022).

Frequently asked questions about Matchpoint Therapeutics

Where is Matchpoint Therapeutics headquartered?

Matchpoint Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Matchpoint Therapeutics do?

Matchpoint Therapeutics Inc. is a pharmaceutical company.

When was Matchpoint Therapeutics founded?

The earliest incorporation on record for Matchpoint Therapeutics Inc. is in 2021, according to public company registers.

Similar companies

Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
Visterra, Inc.Cambridge, Massachusetts, United States
Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
QurAlis CorpCambridge, Massachusetts, United States
Apnimed, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences